Form 8-K Theravance Biopharma, For: Feb 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Theravance Biopharma (TBPH) Misses Q4 EPS by 31c
February 27, 2017 4:09 PM ESTTheravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($1.36), $0.31 worse than the analyst estimate of ($1.05). Revenue for the quarter came in at $5.7 million versus the consensus estimate of $4.9 million.
Outlook
We expect to fund advancements across all stages of our development pipeline, including investment towards... More



